ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare

The fully connected environment, digital technologies and artificial intelligence tools enable optimization of patient care.

Jena, Germany | Dublin, USA | 30 August 2022 | Carl Zeiss Meditec AG

ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advance the future of transformative care in ophthalmology. At ZEISS Innovation Week, September 6-8, 2022, ZEISS Medical Technology will host leading experts in ophthalmology to share their personal experiences of how the power of integrated workflow solutions, data management and a range of new software applications are enabling improved efficiencies and optimization of patient care.

ZEISS will also exhibit at the European Society of Cataract and Refractive Surgeons (ESCRS) Annual Meeting from September 16-20, and the American Academy of Ophthalmology (AAO) Conference September 30 - October 3, providing demos, educational programs, and scientific events discussing how digital technologies can promote clinical efficiency and improved patient outcomes.

“As a leader in digital solutions, ZEISS is setting the standard for new ways to manage care at scale. Using data insights and integrated workflow solutions with artificial intelligence adds value in managing disease progression and the optimization of clinical practices,” said Euan S. Thomson, PhD, President of Ophthalmic Devices and Head of the Digital Business Unit for Carl Zeiss Meditec. “We continue to focus on the development of digital solutions creating the roadmap needed for improved care.”

“The digital workflow is the backbone of a practice because it integrates all the diagnostics, the therapeutics, gives peace of mind and less stress to the clinician and the surgeon,” said Sri Ganesh, MD, Chairman and Managing Director of Nethradhama Hospital, India. “At the end of the day, that is what you want to see - efficiency, safety, more patients that can be accommodated and better results.”

“Our workflow is completely integrated, we're 100 percent paperless, and everything talks to each other,” said Bruce A. Rivers, MD, Envue Eye & Laser Center, Maryland, U.S. “The benefits of this integrated workflow are a happy staff, less work for everybody involved, and everything flows a lot easier, decreasing time, stress, and ultimately improving the patient experience.”

Contact for investors

Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
investors .meditec @zeiss .com

Contact for the press

Laurie Ferguson
Head of Global Communications Ophthalmic Devices
Carl Zeiss Meditec
Phone: +1 925 719 7825
laurie .ferguson @zeiss .com

Brief Profile

Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With approximately 3,531 employees worldwide, the Group generated revenue of €1,646.8m in fiscal year 2020/21 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For further information visit: www.zeiss.com/med

Contact for investors

Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
investors .meditec @zeiss .com

Contact for the press

Laurie Ferguson
Head of Global Communications Ophthalmic Devices
Carl Zeiss Meditec
Phone: +1 925 719 7825
laurie .ferguson @zeiss .com

Share
Further Articles

Change to the Management Board of Carl Zeiss Meditec AG

Management Board member Jan Willem de Cler to leave the Company at his own request and on good terms.

8 Sep 2022

Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22

5 Aug 2022

Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22

Strained supply chain situation in equipment business continues

Carl Zeiss Meditec generated revenue of €855.4m in the first six months of fiscal year 2021/22 (prior year: €767.4m),...

13 May 2022